ME Rothenberg - The new england Journal of Medicine, 1998 - nejm.highwire.org A marked accumulation of eosinophils occurs in several important disorders, such as allergic
diseases, parasitic infections, and cancer. 1 The level of eosinophils in the body is normally tightly
regulated. In normal subjects, eosinophils account for only a small minority of peripheral- ... Cited by 547 - Related articles - BL Direct - All 5 versions
PF Weller, GJ Bubley… - Blood, 1994 - bloodjournal.hematologylibrary.org T HE IDIOPATHIC hypereosinophilic syndrome (HES) is a leukoproliferative disorder, or more
likely disorders, marked by a sustained overproduction of eosinophils. The distinctiveness of
the syndrome, in addition to its eosino- philia, is its marked predilection to damage ... Cited by 479 - Related articles - View as HTML - BL Direct - All 8 versions
M Kitaura, T Nakajima, T Imai, S Harada, C … - Journal of Biological …, 1996 - ASBMB The CC chemokine eotaxin is a selective chemoattractant for guinea pig eosinophils, first purified
from bronchoalveolar lavage fluid in a guinea pig model of allergic airway inflammation. We
have now isolated the gene and cDNA for a human counterpart of eotaxin. The gene ... Cited by 265 - Related articles - BL Direct - All 5 versions
[CITATION] Eosinophils: a comprehensive review, and guide to the scientific and medical …
SS Kushwaha, JT Fallon, V Fuster - The New England journal of …, 1997 - nejm.highwire.org Restrictive myocardial disease may result from various local and systemic disorders, many of
them rare and unlikely to be seen in clinical practice. Other conditions, such as amyloidosis,
are more common, however, and may present with symptoms and signs of congestive ... Cited by 208 - Related articles - All 5 versions
- ►angrylapdog.com J Gotlib, J Cools, JM Malone III, SL Schrier, … - …, 2004 - bloodjournal.hematologylibrary.org. … Protean biologic and clinical presentations characterize idiopathic hypereosinophilia (HES).
HES is similar to other diseases given the moniker "diagnosis of exclusion," in that limited understanding
of the pathogenesis of the disease has hampered therapeutic advances. The ... Cited by 143 - Related articles - BL Direct - All 7 versions
- ►rupress.org [PDF] WF Owen, ME Rothenberg, J Petersen, PF … - Journal of Experimental …, 1989 - jem.rupress.org The idiopathic hypereosinophilic syndrome (IHES) is characterized by sustained peripheral blood
eosinophilia associated with organ involvement in the absence of adefined etiology (1). The
isolation ofeosinophils from patients with IHES hasresulted in the identification of a ... Cited by 140 - Related articles - All 3 versions
- ►nih.gov [PDF] JJ Costa, K Matossian, MB Resnick, WJ … - Journal of Clinical …, 1993 - pubmedcentral.nih.gov By in situ hybridization, 44-100% of the blood eosinophils from five patients with hypereosinophilia
and four normal sub- jects exhibited intense hybridization signals for TNF-a mRNA. TNF-a protein
was detectable by immunohistochemistry in blood eosinophils of hypereosinophilic ... Cited by 139 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org J Cortes, P Ault, C Koller, D Thomas, A … - …, 2003 - bloodjournal.hematologylibrary.org Idiopathic hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterized by
persistent eosinophilia and organ involvement. Different treatments have been investigated in
HES with modest success. It has been suggested that imatinib is active in HES. We ... Cited by 128 - Related articles - BL Direct - All 6 versions
